Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/TECH
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

BIO-TECHNE Corp (TECH) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Bio-Techne (TECH) trades at $72.46, up 0.01% on the day and near its 52-week high of $72.70. The stock shows bullish technical momentum with strong moving average signals and trades just below the analyst consensus price target of $73.00. Recent shareholder approval of the Merck KGaA acquisition at $73.00 per share provides a clear near-term catalyst, while fundamentals show mixed results with a high P/E of 62.47 but improving revenue trends.
The acquisition premium offers limited upside from current levels, though the deal provides valuation support. Risks include integration challenges post-acquisition and recent earnings volatility. With no sell ratings and institutional buying interest, the stock appears fairly valued with the primary catalyst being the pending acquisition completion.
Read full analysis

Key Stats

  • Market Cap
    $11.36B
  • Volume
    2,227,970
  • Sector
    Health
  • 52W High
    $72.61
  • 52W Low
    $43.31
  • Typical Hold Time
    64 Days
  • Enterprise Value
    $11.39B
  • Div Yield
    0.44%
  • Trading Activity
    -
$72.39
52W Low: $43.31
15 May 2026
52W High: $72.61
25 Sep 2026

Track BIO-TECHNE Corp (TECH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, BIO-TECHNE Corp has traded between a low of $43.31 and a high of $72.61, highlighting its annual price range. Buy and sell BIO-TECHNE Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About BIO-TECHNE Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Most Recent News

Content is generated by Aura AI

St. Louis Blues to air 10 Thursday games on Gray Media's ABC 32 in 2026-27 season

The St. Louis Blues and Gray Media announced a multi-year deal to broadcast 10 select Thursday games over-the-air on ABC 32 in St. Louis and 10 other markets during the 2026-27 NHL season. This expands access to Blues games for over 4.8 million house...

Market News
42 minutes ago
Na
Bullish
news icon
St. Louis Blues to air 10 Thursday games on Gray Media's ABC 32 in 2026-27 season

Obexelimab shows sustained benefits in IgG4-related disease, reducing steroid toxicity and supporting vaccine response.

Zenas BioPharma presented new data on obexelimab at the 6th International Symposium on IgG4-Related Disease, highlighting sustained clinical activity in treating IgG4-RD. Phase 3 INDIGO open-label extension results showed a high probability of patien...

Market News
42 minutes ago
Na
Bullish
news icon
Obexelimab shows sustained benefits in IgG4-related disease, reducing steroid toxicity and supporting vaccine response.

Computershare upgrades to OTCQX, enhancing U.S. trading access for its shares and ADRs

Computershare Limited, the world's largest stock transfer agent, has upgraded its U.S. trading status from the Pink Limited Market to the OTCQX Best Market. This move simplifies its trading structure in the U.S. and provides investors with better acc...

Market News
42 minutes ago
Otc Markets Group Inc.
Bullish
news icon
Computershare upgrades to OTCQX, enhancing U.S. trading access for its shares and ADRs
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $11.36B
  • Volume
    2,227,970
  • Sector
    Health
  • 52W High
    $72.61
  • 52W Low
    $43.31
  • Typical Hold Time
    64 Days
  • Enterprise Value
    $11.39B
  • Div Yield
    0.44%
  • Trading Activity
    -
$72.39
52W Low: $43.31
15 May 2026
52W High: $72.61
25 Sep 2026

Track BIO-TECHNE Corp (TECH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, BIO-TECHNE Corp has traded between a low of $43.31 and a high of $72.61, highlighting its annual price range. Buy and sell BIO-TECHNE Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!